Bailard Inc. Purchases Shares of 83,000 Kindred Healthcare, Inc. (KND)

Bailard Inc. purchased a new position in shares of Kindred Healthcare, Inc. (NYSE:KND) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 83,000 shares of the health services provider’s stock, valued at approximately $805,000. Bailard Inc. owned about 0.09% of Kindred Healthcare as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Janus Henderson Group PLC acquired a new position in shares of Kindred Healthcare during the second quarter worth approximately $130,000. Highbridge Capital Management LLC acquired a new position in shares of Kindred Healthcare during the third quarter worth approximately $133,000. Engineers Gate Manager LP acquired a new position in shares of Kindred Healthcare during the fourth quarter worth approximately $153,000. Crossmark Global Holdings Inc. acquired a new position in shares of Kindred Healthcare during the third quarter worth approximately $208,000. Finally, Piedmont Investment Advisors LLC acquired a new position in shares of Kindred Healthcare during the second quarter worth approximately $216,000. Institutional investors own 82.96% of the company’s stock.

Kindred Healthcare, Inc. (NYSE KND) opened at $8.95 on Friday. The company has a debt-to-equity ratio of 6.22, a current ratio of 1.55 and a quick ratio of 1.53. The company has a market capitalization of $782.39, a price-to-earnings ratio of -4.53 and a beta of 1.13. Kindred Healthcare, Inc. has a 12 month low of $5.50 and a 12 month high of $11.90.

A number of research analysts have recently commented on the company. Mizuho set a $9.00 price target on Kindred Healthcare and gave the stock a “hold” rating in a report on Monday, December 18th. Zacks Investment Research upgraded Kindred Healthcare from a “hold” rating to a “buy” rating and set a $11.00 price target for the company in a report on Wednesday, January 10th. Royal Bank of Canada reiterated a “sector perform” rating and set a $8.50 price target (up from $7.50) on shares of Kindred Healthcare in a report on Thursday, November 9th. ValuEngine upgraded Kindred Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, November 9th. Finally, Stifel Nicolaus upgraded Kindred Healthcare from a “sell” rating to a “hold” rating and set a $7.00 target price for the company in a research note on Monday, November 20th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $9.31.

WARNING: “Bailard Inc. Purchases Shares of 83,000 Kindred Healthcare, Inc. (KND)” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/02/17/bailard-inc-purchases-shares-of-83000-kindred-healthcare-inc-knd.html.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Want to see what other hedge funds are holding KND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kindred Healthcare, Inc. (NYSE:KND).

Institutional Ownership by Quarter for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply